Elos Medtech Past Earnings Performance
Past criteria checks 2/6
Elos Medtech has been growing earnings at an average annual rate of 23.4%, while the Medical Equipment industry saw earnings growing at 6.5% annually. Revenues have been growing at an average rate of 9.3% per year. Elos Medtech's return on equity is 7%, and it has net margins of 5.4%.
Key information
23.4%
Earnings growth rate
22.9%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | 9.3% |
| Return on equity | 7.0% |
| Net Margin | 5.4% |
| Next Earnings Update | 29 Feb 2024 |
Recent past performance updates
Recent updates
Calculating The Fair Value Of Elos Medtech AB (publ) (STO:ELOS B)
Oct 11
Is Now The Time To Look At Buying Elos Medtech AB (publ) (STO:ELOS B)?
May 23Here's Why I Think Elos Medtech (STO:ELOS B) Is An Interesting Stock
May 10Returns On Capital Are Showing Encouraging Signs At Elos Medtech (STO:ELOS B)
Apr 17We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt
Mar 24Should Elos Medtech AB (publ) (STO:ELOS B) Be Part Of Your Dividend Portfolio?
Mar 11The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares
Feb 28Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?
Feb 24Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment
Feb 11When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?
Jan 31How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?
Jan 18
Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture
Jan 06Could The Elos Medtech AB (publ) (STO:ELOS B) Ownership Structure Tell Us Something Useful?
Dec 26Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet
Dec 13Here's Why We Don't Think Elos Medtech's (STO:ELOS B) Statutory Earnings Reflect Its Underlying Earnings Potential
Nov 30Elos Medtech AB (publ)'s (STO:ELOS B) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 17Revenue & Expenses Breakdown
How Elos Medtech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 1,018 | 55 | 183 | 21 |
| 30 Jun 23 | 998 | 55 | 184 | 23 |
| 31 Mar 23 | 961 | 76 | 171 | 24 |
| 31 Dec 22 | 889 | 75 | 166 | 24 |
| 30 Sep 22 | 843 | 94 | 158 | 24 |
| 30 Jun 22 | 799 | 90 | 156 | 22 |
| 31 Mar 22 | 747 | 79 | 148 | 19 |
| 31 Dec 21 | 724 | 76 | 139 | 18 |
| 30 Sep 21 | 694 | 67 | 126 | 14 |
| 30 Jun 21 | 655 | 62 | 113 | 14 |
| 31 Mar 21 | 592 | 51 | 106 | 15 |
| 31 Dec 20 | 580 | 36 | 109 | 16 |
| 30 Sep 20 | 584 | 33 | 118 | 18 |
| 30 Jun 20 | 593 | 29 | 122 | 17 |
| 31 Mar 20 | 658 | 29 | 131 | 17 |
| 31 Dec 19 | 689 | 39 | 133 | 17 |
| 30 Sep 19 | 700 | 35 | 131 | 21 |
| 30 Jun 19 | 697 | 32 | 129 | 22 |
| 31 Mar 19 | 679 | 29 | 126 | 21 |
| 31 Dec 18 | 645 | 21 | 121 | 19 |
| 30 Sep 18 | 625 | 24 | 118 | 14 |
| 30 Jun 18 | 603 | 21 | 113 | 13 |
| 31 Mar 18 | 593 | 23 | 109 | 14 |
| 31 Dec 17 | 578 | 23 | 106 | 14 |
| 30 Sep 17 | 562 | 18 | 108 | 15 |
| 30 Jun 17 | 556 | 23 | 107 | 16 |
| 31 Mar 17 | 552 | 29 | 104 | 15 |
| 31 Dec 16 | 552 | 26 | 101 | 15 |
| 30 Sep 16 | 555 | 27 | 96 | 15 |
| 30 Jun 16 | 551 | 20 | 95 | 15 |
| 31 Mar 16 | 539 | 15 | 94 | 15 |
| 31 Dec 15 | 504 | 16 | 93 | 14 |
| 30 Sep 15 | 474 | 17 | 87 | 13 |
| 30 Jun 15 | 436 | 23 | 80 | 11 |
| 31 Mar 15 | 398 | 26 | 72 | 10 |
| 31 Dec 14 | 381 | 23 | 63 | 10 |
| 30 Sep 14 | 371 | 25 | 62 | 10 |
| 30 Jun 14 | 369 | 18 | 60 | 10 |
| 31 Mar 14 | 366 | 17 | 59 | 9 |
| 31 Dec 13 | 368 | 17 | 59 | 9 |
| 30 Sep 13 | 396 | 20 | 66 | 10 |
| 30 Jun 13 | 413 | 18 | 72 | 11 |
| 31 Mar 13 | 424 | 12 | 80 | 12 |
| 31 Dec 12 | 434 | 8 | 88 | 14 |
Quality Earnings: ELOS B has high quality earnings.
Growing Profit Margin: ELOS B's current net profit margins (5.4%) are lower than last year (11.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ELOS B's earnings have grown significantly by 23.4% per year over the past 5 years.
Accelerating Growth: ELOS B's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ELOS B had negative earnings growth (-41.7%) over the past year, making it difficult to compare to the Medical Equipment industry average (-10.8%).
Return on Equity
High ROE: ELOS B's Return on Equity (7%) is considered low.